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Abstract
Background: Childhood asthma is characterized by chronic airway inflammation.
Integrative genomic analysis of airway inflammation on genetic and protein level may
help to unravel mechanisms of childhood asthma. We aimed to employ an integrative
genomic approach investigating inflammation markers on DNA, mRNA, and protein
level at preschool age in relationship to asthma development.
Methods: In a prospective study, 252 preschool children (202 recurrent wheezers, 50
controls) from the Asthma DEtection and Monitoring (ADEM) study were followed
until the age of six. Genetic variants, mRNA expression in peripheral blood
mononuclear cells, and protein levels in exhaled breath condensate for intercellular
adhesion molecule 1 (ICAM1), interleukin (IL)4, IL8, IL10, IL13, and tumor necrosis
factor a were analyzed at preschool age. At six years of age, a classification (healthy,
transient wheeze, or asthma) was based on symptoms, lung function, and medication
use.
Results: The ICAM1 rs5498 A allele was positively associated with asthma develop-
ment (p = 0.02) and ICAM1 gene expression (p = 0.01). ICAM1 gene expression was
positively associated with exhaled levels of soluble ICAM1 (p = 0.04) which in turn
was positively associated with asthma development (p = 0.01). Furthermore,
rs1800872 and rs1800896 in IL10 were associated with altered IL10 mRNA expression
(p < 0.01). Exhaled levels of IL4, IL10, and IL13 were positively associated with
asthma development (p < 0.01).
Conclusions: In this unique prospective study, we demonstrated that ICAM1 is
associated with asthma development on DNA, mRNA, and protein level. Thus,
ICAM1 is likely to be involved in the development of childhood asthma.
Asthma is characterized by chronic airway inflammation and
airway hyper-responsiveness which lead to symptoms such as
wheeze (1, 2). However, wheezing symptoms at preschool age
are mostly transient and caused by viral infections. Only
around 30% of wheezing children at preschool age will have
persistent symptoms and will ultimately develop asthma (2, 3).
The exact mechanisms of childhood asthma are largely unclear
and, therefore, it is not possible to distinguish true asthmatics
from transient wheezers at preschool age (3).
We previously demonstrated that various levels of exhaled
inflammation markers were elevated in children with preschool
wheeze (4). However, in that cross-sectional analysis, we could
not determine the role of these markers in relationship to
asthma development. With an integrative genomic approach
on DNA, mRNA, and protein level, the role of these markers
can be further elucidated. Protein levels can be measured in
exhaled breath condensate (EBC) with adequate sensitivity and
reproducibility (5–7). Pro-inflammatory cytokines (T-helper 1
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cytokine tumor necrosis factor alpha (TNFa) and T-helper 2
cytokines interleukin (IL)4 and IL13), an anti-inflammatory
cytokine (IL10), a chemokine (IL8), and an adhesion molecule
(Intercellular Adhesion Molecule 1 (ICAM1)) were selected for
analysis. All these markers have previously been associated
with childhood asthma and airway inflammation.
We hypothesize that when an inflammation marker is found
to be associated with the development of asthma at the age of
six, causal pathways can be inferred when the data are
combined with DNA and RNA analysis (Fig. 1). The aim of
our unique prospective study is to study inflammation markers




The current study is conducted within the context of the
Asthma DEtection and Monitoring (ADEM) study (8). A total
of 202 children with recurrent wheeze (≥2 episodes during life
according to the ISAAC questionnaire) and 50 healthy controls
(random selection of children without wheezing episodes
during life) at 2–4 years of age were included (9). At preschool
age, saliva or buccal cells (DNA), blood (RNA), and EBC were
collected. If possible, the use of asthma medication was
temporarily stopped prior to the measurement. In case of
symptoms of an airway infection, the measurement was
postponed. Ethical approval was obtained, and all parents
provided written informed consent.
Asthma diagnosis
At the age of six, a classification (healthy, transient wheezer, or
true asthmatic) was assessed by two pediatricians in the field of
respiratory medicine based on recurrent wheeze at inclusion,
current respiratory symptoms, lung function (reversibility to a
B2 agonist and/or bronchial hyper-responsiveness according to
the ERS guidelines) (10, 11), and the use of asthma medication.
A challenge test was performed using histamine dissolved in
physiologic saline in doubling concentrations from 0.032 to
16 mg/ml. The classification ‘healthy’ was given when a child
had no recurrent wheeze at time of inclusion and when asthma
was not diagnosed at 6 years of age. The classification
‘transient wheeze’ was given when a child had recurrent
wheeze at inclusion (defined as ≥2 episodes during life
according to the ISAAC questionnaire), but was not diagnosed
with asthma at 6 years of age. The classification ‘true
asthmatic’ was given when a child was diagnosed with asthma
at 6 years of age. Additionally, this classification was com-
pared with a computer algorithm as described previously (11).
Mismatching cases were reassessed by a blinded pediatric
pulmonologist who decided on the final classification.
DNA isolation and genotyping
Saliva was collected by Oragene DNA self-collection kits
(Oragene, Ottowa, ON, Canada). If children were unable to
produce sufficient saliva, buccal cells were obtained. DNA was
isolated according to the manufacturers’ protocol. Participants
were genotyped for seven single-nucleotide polymorphisms
(SNPs) in six genes (see Table S1 electronic repository) based
on previous association with childhood asthma, the ability to
measure their product in EBC, and a minor allele frequency of
at least 10%. Six of the SNPs were determined using the mass-
spectroscopy based, high-throughput MassARRAY iPLEX
platform (Sequenom Inc., Hamburg, Germany) using two
multiplex genotyping reactions. Primer and probe information
are provided in Table S2 of the electronic repository.
Rs2243250 could not be fitted into the multiplex reactions
and was determined using the TaqMan genotyping assay ID
C_16176216_10 (Applied Biosystems, Carlsbad, CA, USA).
RNA isolation and mRNA expression
Total RNA was extracted from peripheral blood mononuclear
cells (PBMCs) obtained by blood sampling. PBMCs were
isolated with the Qiagen PaxGene Blood RNA kit (Qiagen,
Hilden, Germany). cDNAs were generated by poly-A and
random-primed reverse transcription with the accompanying
Qiagen kit and used for the production of cRNA pools.
Quantitative real-time PCR was performed using the Fluidigm
BioMark system (AROS Applied Biotechnology, Aarhus,
Denmark) to assess expression of the six selected genes (Table
S1 electronic repository). A quality control was conducted
based on slope and appearance of the amplification curve. An
internal standard was obtained by computing the geometric










B = 0.10 
(s.e. 0.05)
AG B = –0.70 
(s.e. = 0.25)
GG B = –0.39 
(s.e. = 0.40)
OR = 1.30 
(CI = 1.06–1.61)
AG OR = 0.60 (CI = 0.35–1.02)
GG OR = 0.38 (CI = 0.17–0.89)
Figure 1 Summary of findings for ICAM1. The effect of genotype on gene expression and in turn on soluble ICAM1 levels in exhaled breath
condensate with, as outcome, the development of asthma. Besides the direct effect of genotype on asthma development is shown. ICAM1,
intercellular adhesion molecule 1; OR, odds ratio; CI, 95% confidence interval; AG, rs5498 genotype AG; GG, rs5498 genotype GG. Significant
results (p < 0.05) are given in bold.
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Cyclophilin A) in each participant. For each selected gene, the
cycle threshold (Ct) value was adjusted by subtraction of the
geometric mean according to this internal standard. In case
two of the three housekeeping genes passed the quality control
(n = 11), the Ct value of the missing housekeeping gene was
replaced by the mean Ct value of this gene within the study
population.
Inflammation markers in Exhaled Breath Condensate
Exhaled breath condensate was collected using a closed glass
condenser system with a breath recirculation unit developed at
our institute (6, 8). Six inflammation markers in EBC (Table S1
electronic repository) were assayed using the multiplex immu-
noassay (Luminex Corporation, Austin, TX, USA Utrecht)
(12). In case of values under the detection limit, a randomly
generated value was added using the uniform distribution
between zero and the detection limit (13).
Statistical analysis
SPSS version 17.0 was used for data analysis (SPSS inc.,
Chicago IL, USA). Due to the skewed distributions, EBC
markers were log-transformed which successfully imparted a
normal distribution. For the relationship between individual
SNPs and childhood asthma and the relationship between
individual protein levels in EBC and childhood asthma, ordinal
regression modeling adjusted for confounders (gender, age,
passive smoking, and exposure to furry pets at home) was used.
All SNPs were tested according to a co-dominant model (two
major alleles 6¼ one minor allele 6¼ two minor alleles) or a
dominant model when the minor allele genotype was present in
<10% of the participants. Linear regression was used for
associations between SNPs and gene expression and associa-
tions between gene expression and inflammation markers in
EBC. The condition at preschool age (recurrent wheeze or
control) and confounders were included in the linear regression
models. Results were expressed in adjusted odds ratio (OR)
with 95% confidence interval (95% CI) in case of logistic
regression and adjusted B with standard error (s.e.) in case of




At preschool age, 252 children were included. Due to personal
constraints of parents (e.g., lack of time or interest), four
children were lost in the follow-up at 6 years of age. One child
from the control group diagnosed with asthma was excluded
from analysis. In total, 247 children were included in the
analysis (76 asthmatics, 122 transient wheezers, and 49 healthy
controls). The agreement between the computer algorithm
classification and the clinical classification was high (91%).
Baseline characteristics are displayed in Table 1. Atopy,
eczema, allergic rhinitis, and the use of asthma medication
were significantly different between the groups, with the
highest frequencies in asthmatic children. Treatment of inhaled
corticosteroids could not be stopped prior to measurement in
six children. A sensitivity analysis excluding these children did
not alter the results. An additional sensitivity analysis exclud-
ing non-white children (n = 10) did not alter the results either.
Consequently, these children were kept in the analysis.
Single-nucleotide polymorphisms in relationship to
classification at age six and mRNA expression
DNA extraction was successful in all children (100%). All
SNPs had a high call rate (96.8–99.6%, Table S1 electronic
repository). No deviation from Hardy–Weinberg equilibrium
was observed in the control group (p ≥ 0.05, Table S1
electronic repository). Furthermore, linkage disequilibrium
was calculated (R2 = 0.27 for IL10 rs1800872 and rs1800896).
Regarding the relationship between SNPs and the classifi-
cation at age six, the ICAM1 rs5498 AA genotype was
associated with an increased likelihood of childhood asthma
compared to the AG genotype (p = 0.02, Table 2, Fig. 1). For











Mean age (s.d.), in years 3.3 (0.5) 3.2 (0.6) 3.3 (0.6)
Gender: male/female, in N 24/25 63/59 46/30
Atopy, in %†,* 23 17 37
Atopy first degree, in %‡ 65 79 79
Eczema, in %* 22 34 47




Use of short-acting B2
agonist, in %*
0 27 53




Exposure to furry pets,
in %
55 46 46
Passive smoking, in % 35 30 30
Availability DNA, in % 100 100 100
Availability RNA, in % 84 92 88
Availability of EBC, in % 98 98 100
s.d., standard deviation; EBC, exhaled breath condensate; N, number
of children; ICS, inhaled corticosteroids.
*p < 0.05.
†Atopy was defined as specific IgE concentration against a mixture of
inhalant and food allergens of ≥0.35 kU/l on the Phadiatop Infant
test (Pharmacia, Uppsala, Sweden).
+Allergic rhinitis was based on the question ‘In the past 12 months,
has your child had a problem with sneezing or a runny or blocked
nose when he/she did not have a cold of the flu?’
‡First degree relative with eczema, asthma, or allergic rhinitis.
§White European descent was defined as at least 2 grandparents
from white European descent.
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the relationship between SNPs and their respective gene
expression, we found that the AG genotype of ICAM1
rs5498 (p = 0.01) and the minor allele of IL10 rs1800896
(p < 0.01) were negatively associated with their mRNA
expression levels, whereas the minor allele of IL10 rs1800872
(p < 0.01) was positively associated with IL10 mRNA expres-
sion levels (Table 3, Fig. 1). Although the GG genotype did
not demonstrate a statistically significant relationship with
ICAM1 mRNA expression, the direction (negative) of the
relationship was the same as for the AG genotype. The
relationship between IL4 and IL13 polymorphisms and their
gene expression was not assessed, as expression was only
detected in a small number of samples (n = 23 and n = 44,
respectively). Alternatively, the direct effect of IL4 and IL13
polymorphisms on levels of IL4 and IL13 in EBC was
analyzed, but did not show any significant association
(p > 0.05, data not shown).
mRNA expression in relationship to exhaled breath condensate
levels
In 25 children, no RNA samples were obtained as these
children refused venous puncture. The mRNA expression
markers could be determined in 91–95% of the samples. A
significant positive association was seen for ICAM1 mRNA
expression level with the concentration of sICAM1 in EBC
(p = 0.04, Table 4, Fig. 1).
Levels in exhaled breath condensate in relationship to
classification at age six
Inflammation markers in EBC were successfully analyzed in all
but three children due to technical problems. EBC markers
were above the detection limit in more than 98% of the
samples. sICAM1 (Fig. 1), IL4, IL10, and IL13 were signifi-
cantly positively associated with the risk to develop asthma
(p = 0.01, p < 0.01, p < 0.01, p < 0.01, respectively, Table 5).
Discussion
In this prospective study, we examined associations between
SNPs, gene expression levels in PBMCs, and protein levels in
EBC for various inflammation markers at preschool age in
relationship to the risk of developing asthma at the age of six.
ICAM1 has previously been shown to play a central role in the
recruitment and migration of leukocytes to sites of inflamma-
tion and has been linked to childhood asthma (5, 14–17). In
this study, the ICAM1 rs5498 A allele was found to be
Table 2 Association between single-nucleotide polymorphisms
(SNPs) and the development of childhood asthma
Gene rs-number Genotype N OR* 95% CI p-value
IL4 rs2243250 CC 175 ref
CT/TT 64 1.70 0.98–2.93 0.06
IL8 rs2227306 CC 89 ref
CT 119 1.11 0.66–1.86 0.70
TT 35 0.53 0.25–1.13 0.10
IL10 rs1800872 GG 131 ref
GT/TT 115 0.80 0.50–1.28 0.35
rs1800896 TT 75 ref
TC 122 0.89 0.52–1.53 0.67
CC 48 0.91 0.46–1.81 0.79
IL13 rs1800925 CC 144 ref
CT/TT 99 1.44 0.89–2.35 0.14
TNFa rs1800629 GG 174 ref
GA/AA 72 1.13 0.67–1.90 0.66
ICAM1 rs5498 AA 81 ref
AG 137 0.60 0.35–1.02 0.06
GG 27 0.38 0.17–0.89 0.02
N, number of children; OR, odds ratio; 95% CI, 95% confidence
interval; ref., reference category; IL, interleukin; TNFa, tumor
necrosis factor alpha; ICAM1, intercellular adhesion molecule 1.
*Adjusted for gender, age, passive smoking, and exposure to furry
pets.
Values in bold are statistically significant, p < 0.05.
Table 3 Association between single-nucleotide polymorphisms
(SNPs) and mRNA expression at preschool age
Gene rs-number Genotype N B* s.e. p-value
IL8 rs2227306 CC 79 ref
CT 106 0.04 0.20 0.86
TT 34 0.45 0.28 0.11
IL10 rs1800872 TT 117 ref
TG/GG 105 0.83 0.16 <0.01
rs1800896 TT 67 ref
TC 111 0.58 0.19 <0.01
CC 43 1.06 0.23 <0.01
TNFa rs1800629 GG 159 ref
GA/AA 63 0.18 0.22 0.41
ICAM1 rs5498 AA 74 ref
AG 122 0.70 0.25 0.01
GG 25 0.39 0.40 0.34
N, number of children; B, regression coefficient; s.e., standard error;
ref., reference category; IL, interleukin; TNFa, tumor necrosis factor
alpha; ICAM1, intercellular adhesion molecule 1.
*Adjusted for group at preschool age, gender, age, passive smoking,
and exposure to furry pets.
Values in bold are statistically significant, p < 0.05.
Table 4 Association between mRNA expression and inflammation
markers in EBC at preschool age
Gene N B* s.e. p-value
IL8 210 0.05 0.06 0.33
IL10 204 0.02 0.07 0.77
TNFa 201 0.02 0.05 0.72
ICAM1 210 0.10 0.05 0.04
N, number of children; B, regression coefficient; s.e., standard error;
IL, interleukin; TNFa, tumor necrosis factor alpha; ICAM1,
intercellular adhesion molecule 1.
*Adjusted for group at preschool age, gender, age, passive smoking,
and exposure to furry pets.
Values in bold are statistically significant, p < 0.05.
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associated with increased mRNA expression of this gene and
an increased likelihood of developing asthma. Association of
the A allele with asthma has previously been reported (14),
although the G allele has also been associated with asthma
(18). Moreover, we demonstrated that increased ICAM1
mRNA levels were associated with increased levels of sICAM1
in EBC, and higher levels of sICAM1 were in turn associated
with an increased risk for asthma development. Furthermore,
levels of IL4, IL10, and IL13 in EBC were positively associated
with the risk to develop asthma. A potential mechanism is that
increased expression and levels of sICAM1 might lead to an
increased binding of leukocytes and thereby increased produc-
tion of inflammation. Taken together, our study indicates that
ICAM1 is a significant marker of and may be involved in
childhood asthma development.
The ICAM1 polymorphism rs5498 G allele results in an
amino acid change in exon 6 (K469E). The domain in the
protein to which this amino acid belongs is subject to debate.
According to one study, the rs5498 polymorphism is located in
the membrane-spanning region, causing a shift in electrical
charge, which may influence anchorage in the membrane,
thereby affecting the ability to bind inflammatory cells (19).
This disagrees with other studies stating that rs5498 is located
outside the membrane (20–22). It has been hypothesized that
this polymorphism can influence protein–protein dimerization
and consequently alters the ability to bind inflammatory cells
(23, 24). Moreover, the rs5498 polymorphism might make
ICAM1 more prone to enzymatic cleavage (21). This may
result in an increased generation of the soluble form of
ICAM1, which could decrease the binding ability of leuko-
cytes. On the other hand, the presence of the A allele has been
shown to lead to alternative splicing, also resulting in an
increased formation of sICAM1 (23). Overall, these data
suggest that the rs5498 polymorphism in ICAM1 may play a
role in the development of airway inflammation by decreasing
the binding capacity of leukocytes. This is in line with data
obtained in animal models, in which the absence of ICAM1
caused reduced leukocyte influx and consequently decreased
airway hyper-reactivity (25).
We demonstrated that the ICAM1 mRNA concentration
was increased among subjects with the ICAM1 rs5498 AA
genotype. This increased concentration may be due to either
linkage of rs5498 with a SNP in the promoter region, a
decreased degradation of the mRNA, or a reduced feedback
mechanism due to alternative splicing and/or generation of
sICAM1. Remarkable in this respect is the positive relation-
ship we have found between ICAM1 mRNA concentration
and levels of sICAM1 in EBC as several processes during
translation and post-modification can influence protein level.
Furthermore, raised ICAM1 mRNA and raised sICAM1
levels have been measured in different compartments. It is
conceivable that increased mRNA concentrations lead to a
higher expression of ICAM1 on the leukocyte cell membrane.
This increased expression is, in turn, expected to enhance the
binding of leukocytes to the affected lung epithelium, thereby
increasing the number of local leukocytes. Consequently, the
total production of inflammation markers might be increased
due to the increased number of leukocytes. This can explain
the higher levels of interleukins and sICAM1 detected in
EBC of asthmatics. Increased levels of interleukins and
sICAM1 in EBC have also been reported previously in
asthmatic children (5, 26).
We found that no association between the studied IL10
polymorphisms and asthma development was observed in our
study, which is in contrast with previous studies (27, 28).
However, we did provide evidence that gene expression of IL10
is decreased in the presence of at least one rs1800896 C allele
and increased in the presence of at least one rs1800872 G allele.
However, gene expression of IL10 was not related to levels of
IL10 in EBC. Nevertheless, in our study, the levels of IL10 in
EBC were positively associated with asthma development.
Previous research has demonstrated low levels of IL10 in
plasma of asthmatic children, but IL10 in EBC did not differ
between healthy controls and asthmatics in other studies (5, 6,
29). As stated before, the relationship between increased IL10
levels and asthma development might be a consequence of the
presence of more leukocytes and consequently increased
inflammation in the lung tissue, and as such is related to
sICAM1 levels.
A major strength of the present study is that we have
prospectively studied inflammation markers in childhood
asthma at gene coding, gene expression, and protein level
with a unique approach. Furthermore, we used a non-
invasive and feasible method to measure airway inflamma-
tion using markers in EBC. Although this technique seems
to be sensitive and reproducible, more research is required
before implementation in daily practice is possible (5–7). The
high follow-up rate (98%) and our diagnostic approach
provided us with a well-defined study population. Moreover,
the use of ordinal regression permitted us to observe
the relationship of inflammation markers with childhood
asthma in three different groups with increasing severity of
symptoms.
However, some limitations need to be taken into account. A
limitation of the current study is that, due to ethical consid-
erations, it was not possible to measure expression of ICAM1
on the cell membrane of local leukocytes in the lungs.
Table 5 Association between inflammation markers in exhaled
breath condensate (EBC) at preschool age and the development of
childhood asthma
Marker N OR* 95% CI p-value
IL4 244 1.42 1.11–1.83 <0.01
IL8 244 1.26 1.00–1.57 0.05
IL10 244 1.43 1.15–1.78 <0.01
IL13 244 1.42 1.12–1.81 <0.01
TNFa 244 1.02 0.81–1.29 0.85
sICAM1 244 1.30 1.06–1.61 0.01
N, number of children; OR, odds ratio; 95% CI, 95% confidence
interval; IL, interleukin; TNFa, tumor necrosis factor alpha; sICAM1,
soluble intercellular adhesion molecule 1.
*Adjusted for gender, age, passive smoking, and exposure to furry
pets.
Values in bold are statistically significant, p < 0.05.
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Consequently, the mRNA samples are at best a reference for
the overall status of the immune system and therefore also of
the lungs. Another possible limitation of our study is that we
have not corrected for multiple testing. It should be noted that
none of the associations would have remained significant after
correction. However, our ICAM1 associations were present on
each tested level. The unequivocalness of these findings points
to an actual association. Finally, we restricted our analysis to
polymorphisms with a minor allele frequency of 10% or
higher. Consequently, we were not able to analyze rare
variants. Thus, some associations with rare variants could
have been missed.
In summary, in this study, we have investigated the role of
SNPs, gene expression, and protein levels in EBC of inflam-
mation markers at preschool age in relationship to asthma
development at 6 years of age. Our results suggest a significant
role of ICAM1 in the development of childhood asthma. We
demonstrated an adverse effect for the ICAM1 rs5498 A allele
which is associated with an increased expression of ICAM1
mRNA, and in turn increased sICAM1 levels in EBC. This
might lead to an increased binding of leukocytes and thereby
an increased production of inflammatory markers, ultimately
leading to the development of asthma.
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